Capital Wealth Planning, LLC
Source: SEC Form 13F · as of Mar 2026Capital Wealth Planning, LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $1.33B in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$1.33B
BioSniper AIPage evidence connected
Prepared research question
What matters most for AMGEN INC (AMGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 1,852,716 | $651.9M |
| MRKMerck & Co., Inc. | 4,516,730 | $543.3M |
| LLYELI LILLY & Co | 30,812 | $28.3M |
| AZNASTRAZENECA PLC | 133,597 | $26.3M |
| NVSNovartis AG | 125,419 | $19.2M |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 886,835 | $16.4M |
| TEVATeva Pharmaceutical Industries Limited | 525,000 | $15.8M |
| ABBVAbbVie Inc. | 57,056 | $12.4M |
| CORCencora Inc. | 26,427 | $8.3M |
| DGXQuest Diagnostics Incorporated | 36,994 | $7.3M |
| JNJJOHNSON & JOHNSON | 5,249 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,880 | $1.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.